简体
  • 简体中文
  • 繁体中文

热门资讯> 正文

Congressional Trading Report: Rep. Thomas Kean Sold Over $31K In Johnson & Johnson Stock

2025-08-21 23:00

August 20, 2025 records indicate that Representative Thomas Kean filed a sale of Johnson & Johnson (NYSE:JNJ), valued between $31,003 and $115,000. According to the August filing, the transaction occurred on July 31, 2025.

Currently, Johnson & Johnson shares are trading up 0.16% at $179.13.

What Representative Has Been Trading Recently

Over the past three years, Thomas Kean executed 105 trades totaling over $427 thousand. The largest of these trades were in Aon and Johnson & Johnson stock. Some of the key transactions the Rep. has executed recently include:

  • Johnson & Johnson (NYSE:JNJ): $15,001 - $50,000 Purchase
  • Stryker (NYSE:SYK): $15,001 - $50,000 Purchase
  • Check Point Software (NASDAQ:CHKP): $15,001 - $50,000 Purchase

Here is a list of Thomas Kean's most recent trades:

Company Ticker Stock Type Amount Transaction Type Transaction Date
Johnson & Johnson JNJ STOCK $15,001 - $50,000 S (Partial) 2025-07-31
Stryker SYK STOCK $15,001 - $50,000 S (Partial) 2025-07-31
Adobe ADBE STOCK $1,001 - $15,000 S 2025-07-29
Check Point Software CHKP STOCK $15,001 - $50,000 P 2025-07-29
Abbott Laboratories ABT STOCK $1,001 - $15,000 P 2025-07-21

Stay informed on Thomas Kean's trades and other members of Congress with our real-time government trades tracking tool!

Why Congressional Transactions Matter

A congressional transaction is when any representative or senator either buys or sells an individual stock.

Anyone working in Congress must file a Periodic Transaction Report to inform the public of their recent transaction within 30 days of being notified of the transaction and within 45 days of the transaction date.

In April 2012, Former President Barack Obama signed the STOCK Act into law. The act prohibits members of Congress from using private information given to them by their position for personal gain such as buying or selling a stock. The act also expanded disclosure requirements for members of Congress by requiring them to file a monthly disclosure.

Why Congressional Transactions Matter

Congressional transactions shouldn't be the primary reason for an investing decision, but they can be an important factor for an investor to consider.

When a senator or representative makes a new purchase, it could be an indication they expect the stock to rise.

A sale, on the other hand, can be made for a variety of reasons, and may not necessarily mean the seller thinks the stock will go down.

This article was generated by Benzinga's automated content engine and reviewed by an editor.

风险及免责提示:以上内容仅代表作者的个人立场和观点,不代表华盛的任何立场,华盛亦无法证实上述内容的真实性、准确性和原创性。投资者在做出任何投资决定前,应结合自身情况,考虑投资产品的风险。必要时,请咨询专业投资顾问的意见。华盛不提供任何投资建议,对此亦不做任何承诺和保证。